| Lifespan Health Services Llc | |
|
2295 Nw Corporate Blvd 231 Boca Raton FL 33431-7373 | |
| (561) 995-9762 | |
| (561) 995-9799 |
| Full Name | Lifespan Health Services Llc |
|---|---|
| Speciality | Psychologist |
| Location | 2295 Nw Corporate Blvd, Boca Raton, Florida |
| Authorized Official Name and Position | Daniel Lobovits (PRESIDENT) |
| Authorized Official Contact | 5619959762 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Lifespan Health Services Llc 2295 Nw Corporate Blvd 231 Boca Raton FL 33431-7373 Ph: (561) 995-9762 | Lifespan Health Services Llc 2295 Nw Corporate Blvd 231 Boca Raton FL 33431-7373 Ph: (561) 995-9762 |
| NPI Number | 1457520025 |
|---|---|
| Provider Enumeration Date | 02/27/2008 |
| Last Update Date | 10/07/2008 |
| Medicare PECOS PAC ID | 6305913542 |
|---|---|
| Medicare Enrollment ID | O20080930000321 |
News Archive
Depomed, Inc. announced today top-line results from the BREEZE 1 and 2 Phase 3 clinical trials evaluating the safety and efficacy of SeradaTM, an investigational non-hormonal extended release formulation of gabapentin for the treatment of menopausal hot flashes.
Errors in diagnosis place a heavy financial burden on an already costly health care system and can be devastating for affected patients. Strengthening certain aspects of a new and evolving model of comprehensive and coordinated primary care could potentially address this highly relevant, but underemphasized safety concern, say Mark Graber, M.D., of Stony Brook University Medical Center, and Hardeep Singh, M.D., M.P.H., of Baylor College of Medicine, in a commentary published in the July 28 issue of the Journal of the American Medical Association.
Malignant gliomas are the most common subtype of primary brain tumor - and one of the deadliest. Even as doctors make steady progress treating other types of solid tumor cancers, from breast to prostate, the most aggressive form of malignant glioma, called a glioblastoma multiforme or GBM, has steadfastly defied advances in neurosurgery, radiation therapy and various conventional or novel drugs. But an international team of scientists, headed by researchers at the Ludwig Institute for Cancer Research (LICR) at the University of California, San Diego School of Medicine, reports in the August 15 issue of Genes & Development that they have discovered a new signaling pathway between GBM cells - one that, if ultimately blocked or disrupted, could significantly slow or reduce tumor growth and malignancy.
PixelOptics of Roanoke, Virginia USA announced today that Panasonic Healthcare Co., Ltd. of Ehime, Japan will manufacture electronic lenses for PixelOptics' electronic focusing eyeglasses named emPower!™. The emPower! eyeglasses focus faster than the blink of an eye, have no moving parts, and change focus without making a sound. In March of 2010 at Vision Expo East in New York, New York, Pixel and Panasonic announced that they have been working together for the last two plus years to develop and optimize Pixel's electronic lenses.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457520025 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TH0100X | Psychologist - Health Service | PY5283 (Florida) | Primary |
| Provider Name | Lisa Faraldo |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1285882050 PECOS PAC ID: 3971660499 Enrollment ID: I20090326000500 |
News Archive
Depomed, Inc. announced today top-line results from the BREEZE 1 and 2 Phase 3 clinical trials evaluating the safety and efficacy of SeradaTM, an investigational non-hormonal extended release formulation of gabapentin for the treatment of menopausal hot flashes.
Errors in diagnosis place a heavy financial burden on an already costly health care system and can be devastating for affected patients. Strengthening certain aspects of a new and evolving model of comprehensive and coordinated primary care could potentially address this highly relevant, but underemphasized safety concern, say Mark Graber, M.D., of Stony Brook University Medical Center, and Hardeep Singh, M.D., M.P.H., of Baylor College of Medicine, in a commentary published in the July 28 issue of the Journal of the American Medical Association.
Malignant gliomas are the most common subtype of primary brain tumor - and one of the deadliest. Even as doctors make steady progress treating other types of solid tumor cancers, from breast to prostate, the most aggressive form of malignant glioma, called a glioblastoma multiforme or GBM, has steadfastly defied advances in neurosurgery, radiation therapy and various conventional or novel drugs. But an international team of scientists, headed by researchers at the Ludwig Institute for Cancer Research (LICR) at the University of California, San Diego School of Medicine, reports in the August 15 issue of Genes & Development that they have discovered a new signaling pathway between GBM cells - one that, if ultimately blocked or disrupted, could significantly slow or reduce tumor growth and malignancy.
PixelOptics of Roanoke, Virginia USA announced today that Panasonic Healthcare Co., Ltd. of Ehime, Japan will manufacture electronic lenses for PixelOptics' electronic focusing eyeglasses named emPower!™. The emPower! eyeglasses focus faster than the blink of an eye, have no moving parts, and change focus without making a sound. In March of 2010 at Vision Expo East in New York, New York, Pixel and Panasonic announced that they have been working together for the last two plus years to develop and optimize Pixel's electronic lenses.
› Verified 5 days ago
News Archive
Depomed, Inc. announced today top-line results from the BREEZE 1 and 2 Phase 3 clinical trials evaluating the safety and efficacy of SeradaTM, an investigational non-hormonal extended release formulation of gabapentin for the treatment of menopausal hot flashes.
Errors in diagnosis place a heavy financial burden on an already costly health care system and can be devastating for affected patients. Strengthening certain aspects of a new and evolving model of comprehensive and coordinated primary care could potentially address this highly relevant, but underemphasized safety concern, say Mark Graber, M.D., of Stony Brook University Medical Center, and Hardeep Singh, M.D., M.P.H., of Baylor College of Medicine, in a commentary published in the July 28 issue of the Journal of the American Medical Association.
Malignant gliomas are the most common subtype of primary brain tumor - and one of the deadliest. Even as doctors make steady progress treating other types of solid tumor cancers, from breast to prostate, the most aggressive form of malignant glioma, called a glioblastoma multiforme or GBM, has steadfastly defied advances in neurosurgery, radiation therapy and various conventional or novel drugs. But an international team of scientists, headed by researchers at the Ludwig Institute for Cancer Research (LICR) at the University of California, San Diego School of Medicine, reports in the August 15 issue of Genes & Development that they have discovered a new signaling pathway between GBM cells - one that, if ultimately blocked or disrupted, could significantly slow or reduce tumor growth and malignancy.
PixelOptics of Roanoke, Virginia USA announced today that Panasonic Healthcare Co., Ltd. of Ehime, Japan will manufacture electronic lenses for PixelOptics' electronic focusing eyeglasses named emPower!™. The emPower! eyeglasses focus faster than the blink of an eye, have no moving parts, and change focus without making a sound. In March of 2010 at Vision Expo East in New York, New York, Pixel and Panasonic announced that they have been working together for the last two plus years to develop and optimize Pixel's electronic lenses.
› Verified 5 days ago
Meryl B. Rome, Md, Pa Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7100 W Camino Real, Ste. 207, Boca Raton, FL 33433 Phone: 561-391-2770 Fax: 561-391-2930 | |
Kegley Counseling, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3200 N Federal Hwy Ste 206-7, Boca Raton, FL 33431 Phone: 404-496-8849 Fax: 404-591-7909 | |
Lifetime Health Services Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 433 Plaza Real Ste 275, Boca Raton, FL 33432 Phone: 786-226-5377 | |
Creative Minds Aba Services Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1700 N Dixie Hwy Ste 122, Boca Raton, FL 33432 Phone: 305-305-3181 | |
Ronald L Seifer Ph D Pa Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7300 W Camino Real, Suite 230, Boca Raton, FL 33433 Phone: 561-699-7455 Fax: 954-340-3407 | |
James Cocores Md Pa Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5301 N Federal Hwy, Suite 270, Boca Raton, FL 33487 Phone: 561-989-9393 Fax: 561-989-9369 | |
L. Dennison Reed, Psy.d., P.a. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4710 Nw Boca Raton Blvd, Suite 104, Boca Raton, FL 33431 Phone: 954-427-8883 Fax: 954-427-3813 |